08 Jun 2021Ended

Lyophilized Drug Product Case Study: Risk Mitigation of Primary Packaging through Physical and Chemical Testing


Estimated Turnout

upto 100
Based on previous editions


Jun 2021


Not Available
Claim event to edit details

Physical and chemical properties of a container closure system for parenterals may affect the drug manufacturing process, product quality and patient .. Read more safety. In the case of a lyophilized product, the risks are mainly associated with design for manufacturability and impact on product quality. An extended stability study was designed to evaluate three halobutyl elastomer formulations for lyophilization stoppers on drug product leachables, residual moisture and container closure integrity of a model lyophilized preparation. The simulated liquid drug product was filled into vials and subsequently lyophilized using suitable lyophilization processing parameters. The lyophilized product was stored at controlled room temperature to be analyzed periodically over 4 years. The chemical and physical data generated provide a better understanding of potential risks. This webinar will showcase a comprehensive approach to understand potential risks to lyophilized drug product quality based on chemical and physical performance testing.

  • Share your Experience
  • Organizer
Logo Follow Company

Business Review Webinars

UK229 Total Events / 4 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results